Cervidil is a drug owned by Ferring Pharmaceuticals Inc. It is protected by 1 US drug patent filed in 2013 out of which all have expired. Based on its patents and exclusivities, its generic launch date is estimated to be Jul 14, 2012. Details of Cervidil's patents and their expiration are given in the table below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| These drug patents focus on the other aspects of the drug like dosage, mode of administration (oral, tablet, capsules, liquids etc). | |||
| US5269321 | Retrievable pessary |
Jul, 2012
(12 years ago) |
Expired
|
US patents provide insights into the exclusivity only within the United States, but Cervidil is protected by patents in multiple countries. Understanding the full scope of patent protection is crucial in strategizing market entry. By looking at the broader patent landscape, you can identify markets with weaker patent protection which could be ideal generic entry points. The following section offers details on Cervidil's family patents as well as insights into ongoing legal events on those patents.
Cervidil's Family Patents
Explore Our Curated Drug Screens
Generic Launch
Generic Release Date:
Cervidil's generic launch date based on the expiry of its last outstanding patent is estimated to be Jul 14, 2012 (This date is subject to change depending upon the patent filing activities by the drug owner or exclusivity additions to its drug application)
Cervidil Generics:
There are no approved generic versions for Cervidil as of now.
About Cervidil
Cervidil is a drug owned by Ferring Pharmaceuticals Inc. It is used for managing pelvic organ prolapse. Cervidil uses Dinoprostone as an active ingredient. Cervidil was launched by Ferring Pharms Inc in 1995.
Approval Date:
Cervidil was approved by FDA for market use on 30 March, 1995.
Active Ingredient:
Cervidil uses Dinoprostone as the active ingredient. Check out other Drugs and Companies using Dinoprostone ingredient
Treatment:
Cervidil is used for managing pelvic organ prolapse.
Dosage:
Cervidil is available in insert, extended release form for vaginal use. Given below is detailed information on Dosage -
| Strength | Dosage Form | Availability | Application Pathway |
|---|---|---|---|
| 10MG | INSERT, EXTENDED RELEASE | Prescription | VAGINAL |